Home > Financial Ratios > GLENMARK PHARMACEUTICALS

GLENMARK PHARMACEUTICALS
EBIT Growth

    Back to All Ratios
AD     Remove this Ad

GLENMARK PHARMACEUTICALS Last 5 Year EBIT Growth History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   EBIT Growth(%) 190.75-6.18-66.140.2217.80

What is the latest EBIT Growth ratio of GLENMARK PHARMACEUTICALS ?

The latest EBIT Growth ratio of GLENMARK PHARMACEUTICALS is 190.75 based on Mar2025 Consolidated results.
Year EBIT Growth
Mar2025190.75
Mar2024-6.18
Mar2023-66.14
Mar20220.22
Mar202117.80

How is EBIT Growth of GLENMARK PHARMACEUTICALS Trending?

Years EBIT Growth % Change
Mar2025 190.75
Positive
Mar2024 -6.18
Negative
Mar2023 -66.14
Negative
Mar2022 0.22
-98.76
Mar2021 17.8 -

Other Financial Ratios of GLENMARK PHARMACEUTICALS


Compare EBIT Growth ratio of peers of GLENMARK PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS ₹55,740.1 Cr 1% -8.5% 37.3% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹408,991.0 Cr 4% -4.9% -2.3% Stock Analytics
DIVIS LABORATORIES ₹162,371.0 Cr 1.1% -9.3% 9.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹135,229.0 Cr -1.3% -3.7% 24% Stock Analytics
CIPLA ₹108,441.0 Cr 1.5% -9.3% -7.3% Stock Analytics
DR REDDYS LABORATORIES ₹106,407.0 Cr 5% -0.1% 3.3% Stock Analytics


GLENMARK PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS

1%

-8.5%

37.3%

SENSEX

2.9%

-1.1%

8.5%


You may also like the below Video Courses